Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs. […]
Source
New patent expiration for Janssen Pharms drug INVOKAMET Read Post »
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. […]
Source
New patent expiration for Helsinn Hlthcare drug ALOXI Read Post »
Annual Drug Patent Expirations for INVOKAMET+XR Invokamet Xr is a drug marketed by Janssen Pharms and is included in one […]
Source
New patent expiration for Janssen Pharms drug INVOKAMET XR Read Post »
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […]
Source
Drug Patent Expirations for the Week of July 28, 2024 Read Post »
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […]
Source
Drug Patent Expirations for the Week of July 28, 2024 Read Post »
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is […]
Source
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Annual Drug Patent Expirations for ZOKINVY Zokinvy is a drug marketed by Eiger Biopharms and is included in one NDA. […]
Source
New patent expiration for Eiger Biopharms drug ZOKINVY Read Post »
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. […]
Source
New patent expiration for Sun Pharm drug WINLEVI Read Post »
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Zr Pharma and is included in one NDA. […]
Source
New patent expiration for Zr Pharma drug RUBRACA Read Post »
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It […]
Source
New patent expiration for Nalpropion drug CONTRAVE Read Post »